Risk of adverse drug reaction sequence variation interpretation:Imp:Pt:Bld/Tiss:Nar:

Preferred Label : Risk of adverse drug reaction sequence variation interpretation:Imp:Pt:Bld/Tiss:Nar:;

LOINC status : TRIAL;

LOINC display name : Risk of adverse drug reaction sequence variation interpretation Nar (Bld/Tiss) [Interp];

LOINC long common name : Genetic variation's effect on risk of adverse drug reaction;

LOINC short name : Adverse drug seq var interp Bld/T-Imp;

LOINC description : The predicted risk of an adverse drug reaction based on the variant(s) detected. For example, a patient who is HLA-B*57:01 positive has a significant risk of abacavir hypersensitivity reactions (HSR). For individuals taking pazopanib and found to be HLA-B*57:01 carriers, they have an increased risk of elevated alanine aminotransferase (ALT) levels when taking pazopanib.;

Details

Origin ID

93308-5;

UMLS CUI

C5211786;

Has component
- Adverse drug reaction [LOINC component]
- Drug [LOINC component]
- Interpretation [LOINC component]
- Reaction [LOINC component]
- Risk of adverse drug reaction sequence variation interpretation [LOINC component]
Has property
- Impression/interpretation of study [LOINC Property]
Has scale
- Nar [LOINC scale]
Has system
- Blood [LOINC System]
- Blood or Tissue [LOINC System]
- Tissue and Smears [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Part of panel
- Carbamazepine hypersensitivity genotype panel:-:Pt:Bld/Tiss:-: [LOINC code]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients